Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
Condition: Coronary Artery Disease Interventions: Drug: Clopidogrel treatment group; Other: No antiplatelet or anticoagulant group Sponsors: Seoul National University Hospital; Hallym University Kangnam Sacred Heart Hospital; Hallym University Medical Center; Hanyang University; Keimyung University Dongsan Medical Center; Kangbuk Samsung Hospital; Wonju Severance Christian Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
Condition: Coronary Artery Disease Interventions: Drug: Clopidogrel treatment group; Other: No antiplatelet or anticoagulant group Sponsor: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Antiplatelet Therapies in Patients With Depression and Coronary Disease
Conditions: Coronary Artery Disease; Depression Interventions: Other: standard Aspirin (ASA) + clopidogrel (CLP) therapy; Other: standard Aspirin (ASA) + Ticagrelor (TCG) or Prasugrel (PSG) therapy; Other: standard ASA therapy Sponsors: Centro Cardiologico Monzino; IRCCS National Neurological Institute " C. Mondino " Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2023 Category: Research Source Type: clinical trials